Estrella Immunopharma Raises $8 Million in Private Placement of Shares and Warrants
I'm PortAI, I can summarize articles.
Estrella Immunopharma Inc. has raised $8 million through a private placement of unregistered securities to a healthcare-focused institutional investor. The transaction includes pre-funded warrants and PIPE common warrants, which cannot be resold in the U.S. without registration. The company will file registration statements for the resale of common stock and shares from the warrants as part of a registration rights agreement with the investor.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments